Welcome to our dedicated page for Vita Coco Company SEC filings (Ticker: COCO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Vita Coco Company, Inc. (NASDAQ: COCO) files reports and disclosures with the U.S. Securities and Exchange Commission as part of its obligations as a public company. This page compiles those SEC filings and pairs them with AI-powered tools that help explain the information contained in key documents.
Through its filings, the company reports on topics such as quarterly and annual financial performance, business developments, and regulatory matters. Recent Form 8-K filings, for example, reference press releases announcing financial results for quarters ended June 30 and September 30, 2025, as well as a company statement regarding tariff relief affecting coconut water products. These filings provide detail on net sales, gross profit, net income, and non-GAAP measures like Adjusted EBITDA, along with management’s commentary on factors such as tariffs, costs, and demand for Vita Coco Coconut Water and related products.
On this page, users can access core documents such as annual reports on Form 10-K, quarterly reports on Form 10-Q, and current reports on Form 8-K as they become available through EDGAR. AI-generated summaries are designed to highlight major themes, clarify technical language, and surface items that may matter to shareholders, such as segment performance, tariff discussions, or capital allocation programs mentioned in earnings releases.
In addition, this page provides convenient access to insider transaction reports on Form 4 and other ownership-related filings when they are filed. Together, these resources allow investors, analysts, and interested readers to review The Vita Coco Company’s regulatory disclosures in one place, with AI assistance to make complex filings easier to understand.
Vita Coco Company, Inc. director Jane Cecil Morreau reported option exercises and a related share sale. On February 23, 2026, she exercised non-qualified stock options in three steps, converting them into a total of 15,000 shares of common stock at $10.178 per share.
That same day she sold 15,000 shares of Vita Coco common stock at an average price of $53.91 per share in an open-market transaction executed under a Rule 10b5-1 trading plan. After these transactions, she directly owned 17,179 common shares of Vita Coco.
Vita Coco Company, Inc. director Kenneth Sadowsky reported an open-market sale of common stock. He sold 3,900 shares of common stock at a weighted average price of $55.64 per share in transactions executed under a pre-arranged Rule 10b5-1 trading plan.
After this sale, Sadowsky holds 604,366 shares of Vita Coco common stock directly. He also holds a non-qualified stock option for 27,300 shares that is fully vested and currently exercisable, providing additional potential equity exposure beyond his current common share holdings.
The Vita Coco Company, Inc. files its annual report describing a coconut-water focused beverage business built on an asset-light global supply chain and two segments: Americas and International. Coconut water accounts for 96% of revenue for the year ended December 31, 2025, making category health and brand strength critical.
The company highlights leadership of its Vita Coco brand in U.S. and U.K. coconut water, expansion into Private Label and PWR LIFT, and reliance on contract manufacturers and Tetra Pak packaging. It outlines extensive risk factors, including supply chain disruptions, raw material and freight cost volatility, customer concentration, intense competition, climate change, regulatory compliance, and obligations tied to its public benefit corporation and Certified B Corporation status.
The Vita Coco Company reported strong fourth quarter and full year 2025 results, with full year net sales of $610 million, up 18%, driven by 26% growth in Vita Coco Coconut Water. Full year net income rose to $71 million from $56 million, and diluted EPS increased to $1.19 from $0.94.
Non-GAAP Adjusted EBITDA grew to $98 million from $84 million, supported by higher pricing and volume, despite tariff and cost pressures. The company ended 2025 with no debt, cash and cash equivalents of $197 million, and executed $11.3 million of share repurchases, leaving $40.9 million authorized.
For fiscal 2026, Vita Coco expects net sales between $680 million and $700 million, gross margin of about 38%, and Adjusted EBITDA between $122 million and $128 million, reflecting continued growth in Vita Coco Coconut Water and improving Private Label trends.
Verlinvest Beverages SA, a Belgian company, reports beneficial ownership of 3,097,161 shares of common stock of The Vita Coco Company, Inc.. This represents 5.4% of the company’s common stock, based on 56,948,258 shares outstanding as of October 27, 2025.
Verlinvest reports sole voting and dispositive power over all of these shares, with no shared voting or investment authority and no group arrangements disclosed. The filing is an amendment to a prior ownership report, confirming Verlinvest as a significant but non-controlling shareholder.
Vita Coco Company, Inc. director Ira Liran reported planned stock sales under a Rule 10b5-1 trading plan. On February 5, 2026, he sold 20,000 shares of common stock directly at a weighted average price of $56.66, leaving 478,341 shares held directly.
On the same date, an additional 30,000 shares of common stock were sold indirectly at a weighted average price of $56.65, with 572,579 shares held indirectly by the Ira Liran 2012 Family Trust. Both reported prices reflect multiple trades within stated intraday price ranges.
Vita Coco Co Inc received an updated ownership report from FMR LLC and Abigail P. Johnson12/31/2025. The filing shows beneficial ownership of 5,152,157.52 shares of common stock, representing 9.0% of the outstanding class.
FMR LLC has sole voting power over 5,147,925 shares and sole dispositive power over 5,152,157.52 shares. Abigail P. Johnson reports sole dispositive power over the same 5,152,157.52 shares, with no voting power. The securities are held in the ordinary course of business and not for the purpose of changing or influencing control. One or more other persons may receive dividends or sale proceeds, but no such person holds more than 5% of the class.
Vita Coco Company, Inc. director Kenneth Sadowsky reported selling 3,900 shares of common stock on January 21, 2026 at a weighted average price of $53.92 per share. The filing states that these sales were made under a pre-arranged Rule 10b5-1 trading plan, meaning the trades were scheduled in advance.
After this transaction, Sadowsky beneficially owned 608,266 shares of Vita Coco common stock in direct ownership. He also holds a non-qualified stock option to buy 27,300 shares of common stock at an exercise price of $10.178 per share, which is fully vested and currently exercisable and expires on January 2, 2030.
Vita Coco Company, Inc. director Shelley G. Broader reported an equity award of 520 shares of common stock in the form of restricted stock units (RSUs) on 01/07/2026. The RSUs were granted at a price of $0.00 per share under the company’s 2021 Incentive Award Plan.
The 520 RSUs vest in full on the earlier of the day immediately preceding the next annual stockholders meeting after the grant date or the first anniversary of the grant date, as long as Broader remains in continuous service through the applicable vesting date. Following this grant, Broader beneficially owns 520 common shares directly.